Rare diseases
Investigational molecules
Locations
Back to France1 clinical trial in Langon, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)FranceThe busiest research cities in the country
What the registry says about research in the country
Ongoing clinical investigations focusing on colon cancer treatment optimization, specifically evaluating the combination of Irinotecan and Oxaliplatin in adjuvant therapy settings.
Research aims to improve long-term outcomes for patients with high-risk stage III colon cancer through innovative combination therapy approaches.
Specialized research examining advanced treatment protocols for high-risk colorectal cancers, with emphasis on post-surgical therapeutic interventions.
The study focuses on measuring three-year disease-free survival rates in patients receiving targeted combination chemotherapy.
Investigation into combination chemotherapy effectiveness, specifically studying the synergistic effects of two established cancer-fighting agents.
Research evaluates the efficacy of combined therapeutic approaches in preventing cancer recurrence after primary treatment.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
